Biomedical & Medtech Manufacturing
Novartis Singapore
UNCLAIMED RECORD · Claim it →Operates a biologics drug-substance facility at Tuas built with an investment of over US$500 million — its first biomanufacturing plant in Asia, using cell-culture production — alongside a separate solid-dosage (tablet) small-molecule plant through Novartis Singapore Pharmaceutical Manufacturing (NSPM).
Capabilities
Sources
CLAIM THIS RECORD
Is this your company?
Novartis Singapore is on the Singapore Industry Index as a reference record, compiled from public sources. Claiming it is free — correct the facts, add capabilities and certifications, appear on more pages, and receive enquiries routed directly to you.
Spotted an error? Claiming is the fastest way to fix it — or write to us via Contact.